Experience with large-dose intravenous antithymocyte globulin in primates and man.
D000818:Animals; D000961:Antilymphocyte Serum / Q000096:biosynthesis* / Q000494:pharmacology; D005260:Female; D006087:Graft vs Host Reaction; D006648:Histocompatibility; D006736:Horses; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008954:Models, Biological; D011817:Rabbits; D016038:Skin Transplantation; D013950:Thymus Gland / Q000276:immunology; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D005719:gamma-Globulins / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity
D000961:Antilymphocyte Serum; D005719:gamma-Globulins